Fabrication and testing of a real-time nicotine detector for digital health management

用于数字健康管理的实时尼古丁检测器的制造和测试

• 批准号: 542826-2019
• 负责人: Yadav, VikramadityaGanapati
• 金额: $ 1.82万
• 依托单位: University of British Columbia
• 依托单位国家: 加拿大
• 项目类别: Engage Grants Program
• 财政年份: 2019
• 资助国家: 加拿大
• 起止时间: 2019-01-01 至 2020-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=680713
• 关键词: Fabrication; testing; real; time; nicotine

Chronic obstructive pulmonary disease (COPD) is the leading cause of hospital admissions among major chronic illnesses in Canada and costs taxpayers roughly $1.5 billion each year. Although there are no cures for COPD, effective management of the disease through early detection and continuous monitoring has been shown to reduce costs and improve patient outcomes. Agartee Technology Inc. is a Canadian digital healthcare start-up that has developed a novel health tracking platform to actively monitor key indicators of COPD using proprietary sensors. The platform then relays this information to healthcare providers in real-time, thereby allowing them to make informed decisions to improve the patient's quality of life. The current collaborative project between the University of British Columbia and Agartee aims to extend the capabilities of the platform to also detecting nicotine in the ambient air. Nicotine in second-hand smoke can greatly exacerbate COPD and augmenting the current platform with a nicotine sensor and alerting system could further improve the quality of management of the disease. The nicotine sensor and alerting system would be constructed using novel and robust yet cheap conducting polymer films and electronic components and will seamlessly integrate with Agartee's current platform. The construction of low-cost and durable health monitoring systems of the type that we are proposing will prove to be game-changers for the healthcare system.

慢性阻塞性肺疾病(COPD)是加拿大主要慢性病中住院的主要原因，每年花费纳税人约15亿美元。尽管慢性阻塞性肺病没有治愈的方法，但通过早期发现和持续监测对疾病进行有效管理已被证明可以降低成本并改善患者预后。Agartee Technology Inc.是一家加拿大数字医疗初创公司，该公司开发了一种新型健康跟踪平台，使用专有传感器主动监测COPD的关键指标。然后，该平台将这些信息实时传递给医疗保健提供者，从而使他们能够做出明智的决定，以提高患者的生活质量。不列颠哥伦比亚大学和Agartee目前的合作项目旨在将该平台的能力扩展到也检测环境空气中的尼古丁。二手烟中的尼古丁会极大地加剧COPD，为现有平台增加尼古丁传感器和警报系统，可以进一步提高对疾病的管理质量。尼古丁传感器和警报系统将使用新型、坚固但廉价的导电聚合物薄膜和电子元件构建，并将与Agartee目前的平台无缝集成。事实证明，构建我们所提议的那种低成本和耐用的健康监测系统将改变医疗保健系统的游戏规则。